Natural killer (NK) cells are innate lymphocytes that control tumors and viruses (Vivier et al. 2011; Yokoyama 2013) . Unlike other lymphocytes, that is, T and B cells, NK cells classically exert their effector functions without prior sensitization and do not somatically rearrange their receptor genes (Hackett et al. 1986 ). Instead, NK cells rely on a fixed number of germline-encoded inhibitory and activation receptors capable of recognizing major histone compatibility complex (MHC) Class I (MHC-I), MHC-I-like molecules, and other ligands (Karlhofer et al. 1992; Brown et al. 2001; Iizuka et al. 2003; Lanier 2005; Bryceson and Long 2008) . NK-cell effector functions can be triggered by engagement of NK-cell -activation receptors with target-cell-surface ligands, some of which are up-regulated by infected cells or tumors (Arase et al. 2002; Smith et al. 2002; Guerra et al. 2008; Raulet et al. 2013) . NK cells also respond to antigen-presenting cell (APC)-derived cytokines, allowing NK cells to mediate early host responses by producing other proinflammatory cytokines that affect other immune cells (Biron et al. 1999; Krug et al. 2004; Moretta et al. 2006) . Most of our current knowledge of NK cells, however, is derived from studies of mouse splenic and human peripheral blood NK cells, hereafter referred to as "conventional" NK cells.
NK cells are also present in other tissues and organs. Because this topic has been extensively reviewed recently (Shi et al. 2011) , in this treatise, we highlight a few points relevant to recent advances indicating that certain NK-cell subsets can be found to reside in certain tissues and migrate poorly to other anatomic regions, that is, these subsets represent tissue-resident NK cells.
CONVENTIONAL NK-CELL DEVELOPMENT
Conventional NK cells are derived from precursor cells in the bone marrow (BM) Di Santo 2006) , where their development can be divided into several steps (Kondo et al. 1997; Rosmaraki et al. 2001; Igarashi et al. 2002) . Hematopoietic stem cells (HSCs) become committed to lymphoid lineage, becoming early lymphoid progenitors (ELP; lineage-negative [Lin 2 ] cKit high Sca1 þ Flt3 þ ) (Igarashi et al. 2002) and then common lymphoid progenitors (CLPs; Lin 2 cKit low Sca1 low IL7Ra þ ) (Kondo et al. 1997) . Expression of CD122 (IL2/IL15Rb) traditionally defines the transition from CLPs to NK-cell precursors (NKPs) committed to the NK-cell lineage (Rosmaraki et al. 2001) . However, an earlier progenitor CD122 2 population ( pre-NKP) in the BM was recently identified (lin
2 ) (Fathman et al. 2011 ). When adoptively transferred, these cells gave rise to donor-derived NK cells in the BM, blood, and spleen, but in no other cell lineages. The maturation of NKPs to immature NK (iNK) cells and later to mature (mNK) cells is further characterized by several putative intermediate stages, based on marker expression . Expression of CD122 on NKPs marks intermediate Stage I, whereas Stage II NK cells express NK1.1, CD94/ NKG2, and NKG2D. During Stages III and IV, immature NK cells express CD117, Ly49 receptors, and integrin a 2 (DX5). At Stage IV, immature NK cells proliferate. After expansion, iNK cells become mNK cells, expressing high levels of CD11b (Mac1), CD43, and effector functions, that is, target killing and cytokine production. The most mature BM NK cells resemble the majority of splenic NK cells, although down-regulation of CD27 on splenic CD11b þ NK cells is associated with further differentiation (Hayakawa and Smyth 2006) . Thus, conventional NK cells progress through several steps, akin to T-and B-cell development, en route to becoming phenotypically and functionally mature splenic NK cells Di Santo 2006) , but it is important to note that these putative developmental stages are largely based on correlating marker expression in vivo.
In vitro differentiation studies indicate that cells with NK-cell phenotype can be derived from BM ELPs cultured with certain cytokines (stem cell factor [SCF], Fms-related tyrosine kinase 3 ligand [Flt3L], IL7, and IL15) (Williams et al. 1997 (Williams et al. , 1999 Roth et al. 2000) . However, in the absence of direct contact with BM stromal cells, such as OP9 cells, developing NK cells are relatively immature (Williams et al. 1999 (Williams et al. , 2000 Roth et al. 2000) . Although these earlier in vitro studies need to be reexamined in light of current knowledge of NK-cell differentiation in vivo, these studies indicate that soluble and contact-dependent factors are required for full maturation of conventional NK cells.
NK CELLS IN OTHER ORGANS
Uterine NK cells NK cells are found in high numbers in unusual areas such as the lining of the uterus. Originally described by morphologists as "granulated uterine metrial gland" cells, NK cells are the most abundant leukocyte at the site of embryo implantation, where they can regulate placental vascularization and pregnancy outcomes (Croy 1994; Ashkar et al. 2000; Croy et al. 2006; Moffett and Loke 2006; Hiby et al. 2010; Manaster and Mandelboim 2010; Chakraborty et al. 2011; Madeja et al. 2011) . Thus, in certain tissues, NK cells can have more specialized functional roles than have been apparent by study of conventional NK cells.
Lymph Node NK cells
NK cells are relatively uncommon in lymph nodes (LNs), unlike T and B cells. Although NK cells in LNs expand in number during certain immune conditions, most of this expansion appears to be due to recruitment rather than in situ proliferation. For example, NK cells can be recruited to draining LNs by activated dendritic cells (DCs) (Martin-Fontecha et al. 2004) . During orthopoxvirus infection, NK cells are recruited to the draining LN (Parker et al. 2007; Fang et al. 2008; Pak-Wittel et al. 2013) . The recruited NK cells resemble splenic NK cells by phenotypic markers; adoptively transferred splenic NK cells also appear in the draining LN in a pertussis-toxinsensitive manner partially dependent on the chemokine receptor CXCR3 (Pak-Wittel et al. 2013) . Recruitment required IFNg because recruitment did not occur in IFNg receptor -deficient mice or when wild-type (WT) mice were administered anti-IFNg-neutralizing antibody. In turn, IFNg induced production of CXCL9 and CXCL10, chemokine ligands for CXCR3. Similarly, NK cells are increased in the peritoneal cavity after intraperitoneal injection of vaccinia virus (Prlic et al. 2005 ). This expansion is also pertussis-toxin sensitive and occurs with little in situ proliferation, even though there are resident peritoneal NK cells in naive mice (Gonzaga et al. 2011) , indicating recruitment of conventional NK cells to peritoneal cavity during infection. Although the chemokines and chemokine receptors involved in peritoneal cavity recruitment have not been elucidated, conventional NK cells can be recruited to LNs and other tissues during immune responses.
Thymic NK cells
Despite original descriptions of NK cells as being thymus independent, recent studies indicate that the thymus contains an NK-cell subset phenotypically distinct from splenic NK cells (Vosshenrich et al. 2006 þ NK cells were also found in LNs (17%) but were unusual (,5%) in other organs such as BM, liver, and spleen. The transcription factor GATA-3 is required for the development of these cells because these cells were absent in GATA-3 -deficient mice. Moreover, these cells are absent in athymic nude (Foxn1 2/2 ) mice, and transplanted normal thymi seeded CD127 þ NK cells into host LN, indicating that a functional thymus is required for their development.
Interestingly, various fetal organs have CLPs that can differentiate into bipotential progenitors (T/NKPs) that can give rise to T or NK cells (Rodewald et al. 1992; Carlyle et al. 1997; Jaleco et al. 1997; Ikawa et al. 1999; Michie et al. 2000; Douagi et al. 2002) . For example, T/ NKPs in the fetal thymus can differentiate into either TCRab T cells or NK cells (Carlyle and Zuniga-Pflucker 1998) . In the adult thymus, a subset of double-negative
2 ) cells, contains T/NKPs (Schmitt and Zuniga-Pflucker 2002; Porritt et al. 2004; Schmitt et al. 2004) . When DN1 cells were cultured with untransfected OP9 cells, they developed into B and NK1.1 þ cells, whereas T cells developed when exposed to Notch-receptor-ligandtransfected OP9 cells (Schmitt and Zuniga-Pflucker 2002; Porritt et al. 2004 , validating the usefulness of these mark-ers in following NK-cell development in vivo. Thus, thymic NK cells develop from a thymocyte progenitor (DN1) population.
Thymic NK cells are generally less efficient at target killing but are better at producing cytokines as compared with splenic NK cells (Vosshenrich et al. 2006 ). This functional difference resembles human peripheral blood CD56 bright NK cells that do not kill as well and are better at producing cytokines, compared with CD56 dim NK cells that comprise the majority of peripheral blood NK cells (Cooper et al. 2001; Vosshenrich et al. 2006) . However, it
is not yet known whether CD56 high NK cells are derived from the thymus. Although the physiological function of thymic NK cells remains unclear, other studies have suggested that developing T cells can be susceptible to attack by NK cells (Schott et al. 2003) , presumably by thymic NK cells.
Liver NK cells
"Pit cells" were first described by electron microscopy (EM) of rat liver in the year following the initial description of NK cells (Herberman et al. 1975; Kiessling et al. 1975; Wisse et al. 1976 ). The name "pit" was coined for the characteristic cytoplasmic granules resembling grape pits. These cells are found in other species, including humans and mice, and are now known to be NK cells (Kaneda and Wake 1983; Bouwens et al. 1987; Kaneda 1989) . Pit cells are physically in the sinusoid lumen, facing the blood, and are associated with sinusoidal endothelial cells and Kupffer cells, the resident liver macrophages (Kaneda 1989; Wisse et al. 1996) . A specialized role for pit cells has not been described (Bouwens et al. 1987; Luo et al. 2000; Wiltrout 2000) , but liver NK cells have been reported to mediate several different functions relevant to different liver disorders, such as hepatitis and hepatic fibrosis (for review, see Gao et al. 2009 ).
Other early studies indicated that single-cell suspensions from the liver contain high percentages of NK cells ( 50% of lymphocytes) (Crispe 2009 ) that are somewhat different from conventional NK cells. For example, we and other researchers showed that the liver contains a high frequency (up to 50%) of NK cells with phenotypic markers characteristic of immature conventional NK cells, such as TNF-related apoptosis-inducing ligand (TRAIL) and absence of DX5 Takeda et al. 2005; Gordon et al. 2012) , whereas NK cells at other peripheral sites are TRAIL 2 DX5 þ and predominantly mature in phenotype. During early life, phenotypically immature NK cells predominate in the liver and spleen (Takeda et al. 2005) . After birth, liver NK cells become a stable subpopulation in adult mice, with relatively low steady-state proliferation, whereas the splenic subset declines sharply (Gordon et al. 2012; Wu et al. 2012) . Thus, early studies suggested that the liver might contain an organ-resident NK-cell subset, distinguishable from conventional NK cells, perhaps akin to the thymus.
Challenges to identifying such a putative liver-specific NK-cell subpopulation are related to several unique aspects of the liver, including two afferent vascular supplies, and distinctive immunological features (Crispe 2009 ). Through the portal vein that drains abdominal organs, including the spleen, the liver receives 75% of its afferent blood, thereby exposing it to antigens and microbial products from the gastrointestinal tract. This nutrient-rich venous blood mixes in the sinusoids with oxygenated arterial blood from a second afferent vascular source, the hepatic artery. The sinusoids represent a highly fenestrated, low-pressure vascular system containing many innate immune cells. Thus, if the liver contains organ-resident NK cells, they should reside in the sinusoids where they are likely to be mixed with circulating NK cells.
LIVER-RESIDENT NK CELLS
We recently showed that a subpopulation of NK cells selectively resides in the liver, that is, liver-resident NK cells (Peng et al. 2013 ). Here we summarize the findings.
Liver NK cells apparently mediate antigen-specific memory-like responses (O'Leary et al. 2006; Paust et al. 2010; Rouzaire et al. 2011 ). In particular, upon sensitization with haptens, virus-like particles (VLPs), or vaccinia virus, liver, but not splenic, NK cells confer memory-like responses. These responses were first shown by flank skin exposure to haptens (sensitization), a rest period, then reexposure (the challenge) to the specific hapten on the ear, as indicated by swelling, akin to contact hypersensitivity (CHS) (O' Leary et al. 2006) . These responses were seen in WT and Rag-deficient mice lacking T and B cells but having NK cells and were absent in Rag 2 IL2Rg chain (common g chain, gc)-double-deficient mice that lack NK cells. Adoptive transfer of liver, but not splenic, NK cells from sensitized mice to Rag1 2/2 gc 2/2 mice restored CHS but only when challenged with the sensitizing hapten. Finally, the relevant NK cells were found in CHS lesions. Similar studies with other haptens, VLPs, and vaccinia virus from at least two different laboratories indicate that liver, but not splenic, NK cells are responsible for "antigen-specific" memory-like responses.
"Memory" NK cells in the liver express Ly49C/I, CXCR6, and/or Thy1 (O' Leary et al. 2006; Paust et al. 2010; Gillard et al. 2011) , molecules also expressed on other cells, including splenic NK cells (Paust and von Andrian 2011; Vivier et al. 2011 ). The chemokine receptor CXCR6 is expressed on 35% -55% of liver NK cells and a few splenic NK cells (Paust et al. 2010) . CXCR6 deficiency or anti-CXCR6 treatment of CXCR6 þ mice abrogated NK-cell-mediated CHS. Furthermore, CXCR6-expressing cells from the liver, but not the spleen, home to the liver, and CXCR6-deficient mice lack normal numbers of liver NK cells. However, CXCR6 þ and CXCR6 2 liver NK cells both home to the liver, suggesting that CXCR6 is an imperfect marker of liver-resident NK cells and CXCR6 þ NK cells reside outside the liver, where they could be "primed" (Paust et al. 2010; Paust and von Andrian 2011) . Alternatively, the liver contains mixed populations of NK cells. Therefore, liver NK cells appear capable of memory-like properties against "antigens," but previous studies did not define a pheno-type that can unequivocally distinguish them from other NK cells.
Since hepatic, but not splenic, NK cells confer CHS (O' Leary et al. 2006; Paust et al. 2010; Gillard et al. 2011; Rouzaire et al. 2011) , we hypothesized that CHS is due to a distinct NK-cell subset present in liver but not spleen. Indeed, a high proportion of liver NK cells are DX5 2 , which we previously speculated to be an immature population similar to that in BM . Approximately 50% of hepatic NK1.1 þ CD3 2 NK cells were DX5 2 , which constituted only 5% -8% of NK cells in other organs (Peng et al. 2013 2 NK cells specifically home to the liver are phenotypically stable and specifically confer CHS.
The absence of DX5 is of limited value in identifying a unique NK-cell subpopulation because immature, conventional NK cells are also DX5
2 . To identify a marker positively associated with liver DX5
2 NK cells, we performed gene expression microarrays of messenger RNA (mRNA) from liver DX5 2 NK cells and other subsets. We then confirmed differential expression by quantitative reverse-transcription polymerase chain reaction (RT-PCR) and flow cytometry. Consistent with previous results (Paust et al. 2010; Gillard et al. 2011) , we confirmed expression of CXCR6 and Thy1 on a high percentage of liver DX5
2 NK cells, but they were also expressed on conventional DX5
þ NK cells in other tissues (Peng et al. 2013) . Most importantly, we found that all liver DX5 2 NK cells selectively and exclusively expressed CD49a that is not expressed on NK cells from other tissues, including spleen and BM (Fig. 1) (Peng et al. 2013) .
To test the role of liver CD49a þ NK cells in CHS, we performed adoptive transfer experiments (Peng et al. 2013 Interestingly, when we stained blood derived from the sinusoids, we detected CD49a þ DX5 2 NK cells that were not in blood obtained from afferent and efferent liver vessels, whereas CD49a 2 DX5 þ NK cells were found in all blood sources tested (Fig. 2) . To further study liver NK cell trafficking without adoptive transfer, we turned to a parabiosis approach in which surgically conjoined normal mice, distinguished by CD45 allotypes, develop a common circulatory system within a few days (Wright et al. 2001) . When there was substantial chimerism of splenic leukocytes, both parabionts had CD49a 2 DX5 þ (conventional) NK cells in their spleens and livers from the other parabiont ( Fig. 3; see Peng et al. 2013) . In contrast, the liver of each parabiont only had CD49a þ DX5 2 (liver-resident) NK cells of host origin with a few, if any, CD49a
2 NK cells from the other parabiont. Therefore, adoptive transfer, vascular sampling, and parabiosis studies indicate that the liver contains two populations of NK cells: CD49a þ DX5 2 NK cells that are stable residents of liver sinusoids and CD49a
2

DX5
þ NK cells that are in the circulatory system and pass through the liver under noninflammatory homeostatic conditions.
TISSUE-RESIDENT NK CELLS
Now that we have established the presence of liverresident NK cells, there are several potential implications of our findings.
1. Other tissues may have tissue-resident NK cells.
Here we define tissue-resident NK cells as those that remain in their tissue under steady-state conditions and show minimal tendencies to recirculate. Whereas the adoptive transfer studies showing homing of the cells back to their tissue support this property, these approaches require cellular isolation with mAbs that could affect cellular migration. More convincing findings are the absence of tissue-resident NK cells in afferent and efferent blood vessels and their presence in the tissue of interest (Peng et al. 2013) . Finally, parabiotic mice are extremely useful for showing migratory patterns of potential tissueresident NK cells with minimal manipulation of the cells themselves. 2. Like the liver, other vascular tissues may contain both tissue-resident NK cells and a large pool of circulating "conventional" NK cells. Without markers to distinguish these two subpopulations, analysis of single-cell suspensions of these organs may reveal the summation of distinct populations. 3. How liver-resident cells are developmentally related to conventional, thymic, and uterine NK cells remains to be determined. 4. Tissue-resident NK cells may express markers that are similar to immature conventional NK cells Peng et al. 2013 ). a. Tissue-resident NK cells may undergo further maturation, perhaps stimulated by inflammatory conditions, in the tissue of residence, and they may emigrate to become peripheral NK cells. Thymic NK cells reflect one example of this process (Vosshenrich et al. 2006 ). b. Alternatively, tissue-resident NK cells could be relatively "mature," and it is misleading to describe them as immature because their development may not be reflected by conventional NK-cell maturation. c. To distinguish between the above two possibilities, developmental and lineage studies are required to determine whether tissue-resident NK cells share a common progenitor with conventional NK cells or whether they represent distinct lineages. One approach would be to study the role of transcription factors (TFs). A particularly interesting pair of TFs is T-bet (Tbx21) and Eomesodermin (Eomes), which are homologous T-box proteins required for conventional NK-cell development (Townsend et al. 2004; Gordon et al. 2012) . Interestingly, Eomes-negative NK cells are enriched in the liver and do not express DXS, although CD49a was not examined (Gordon et al. 2012) . On the other hand, these cells expressed T-bet, and Tbx21 2/2 mice had enrichment of DX5 þ TRAIL 2 NK cells (Gordon et al. 2012) , suggesting that T-bet may be required for CD49a þ NK-cell development but is only partially required for conventional NK-cell development. However, this study is not complete because whether the Tbx21 effect is NK-cell intrinsic or extrinsic was not addressed, and CD49a þ NK cells were not examined.
5. It is possible that markers that discriminate tissueresident NK cells from conventional NK cells will change during inflammation. Stability of these markers needs to be established. 6. The basis for tissue residency is not entirely clear.
For liver-resident NK cells, CXCR6 appears to have role (Paust et al. 2010) . However, the mutually exclusive expression of integrins (CD49a, DX5) raises the possibility that they may also be involved. Alternatively, CD49a could be relevant to interactions (Peng et al. 2013) . This is somewhat analogous to thymic NK cells, which arise from progenitor cells in the adult thymus.
9. Intriguingly, the fetal liver is the initial site of hematopoiesis, raising the possibility that liver-resident NK-cell progenitors may be seeded early in life. This is akin to other innate cells, such as tissue-resident macrophages that are seeded in early life and self-renew in the adult, independent of circulating monocytes (Schulz et al. 2012; Hashimoto et al. 2013 ).
10. Liver-resident NK cells may have specialized functions, akin to uNK cells (Croy et al. 2006) . Liver NK cells have been implicated in a wide variety of different pathological processes such as liver fibrosis and regeneration, hepatitis, and pathogen defense as well as tumor surveillance of primary liver cancer and metastatic disease (Gao et al. 2009 ). Whether these functions are mediated by liver-resident or conventional NK cells requires further examination.
11. Studies of "memory" liver NK cells led us to discover liver-resident NK cells. NK-cell memory remains a controversial topic because it is not yet clear how NK cells could recognize a wide variety of "antigens" without somatic rearrangement, and the assays for memory effects are largely based on skin inflammation as measured by differential skin thickness (between solvent alone and hapten dissolved in solvent) (O'Leary et al. 2006; Paust et al. 2010; Gillard et al. 2011) . Published studies now indicate that NK memory-like effects are evident in FACS-based CD107a degranulation assays and, importantly, differences in survival (although modest) from viral challenge (Paust et al. 2010; Gillard et al. 2011 ). However, we have had difficulty repeating the CD107a assays. Further advancements in this area will require robust, highly reproducible, and quantitative assays for memory. Nonetheless, the apparent involvement of liver-resident NK cells in CHS suggests alternative views on how these NK cells are "primed," potentially in the liver itself, rather than in a draining LN akin to T-cell priming, as previously proposed (Paust and von Andrian 2011) .
12. Tissue-resident NK cells may interact specifically with other tissue-resident immune cells, as suggested by EM studies of pit cells, which are likely to be liver-resident NK cells (Wisse et al. 1976; Kaneda 1989) . Pit cells are often found adjacent to Kupffer cells. These interactions may be critical to the inherent functions of each tissue-resident immune cell.
CONCLUSIONS
Here, we have attempted to build a case to reconsider NK cells in a different light. Our studies, and those of other researchers, now indicate that the liver normally contains two populations of NK cells: one that is resident in the liver and the other that is present in the circulatory system and is passing through the liver. The liver-resident NK cells have distinct features, suggesting that they may have different functions from conventional NK cells and may have a role in liver diseases. Their developmental pathways may differ somewhat to establish their anatomical niche. Finally, our studies suggest that emerging principles regarding these cells could be applied to NK cells in other tissues.
